Intrinsiqq
Onconetix Inc. logo

Onconetix Inc. Insider Trading

ONCO

⊜ Compare
Last 12 months

No open-market buying or selling by insiders.

No executive or director has bought shares on the open market in the last two years.

Net open-market
$0
0 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
0 / 0
executives and directors
Last open-market buy
None
in the last two years

Get an email when ONCO's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Apr 21No plan
    HRT Financial LP
    Large holder · sold 49,710 at $0.69
    34K
    60% of stake
  • Apr 16 – 20No plan
    HRT Financial LP
    Large holder · sold 148,329 at avg $0.74
    110K
    64% of stake
  • Apr 17
    HRT Financial LP
    Large holder · bought 34,636 at $0.73
    25K
    71% of stake
  • Apr 14 – 15
    HRT Financial LP
    Large holder · bought 166,904 at avg $0.76
    128K
    554% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ONCO, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ONCO

CompareIntrinsic value
RLYBRallybio Corporation
$15.90+0.25%62
UNCYUnicycive Therapeutics Inc.
$3.75+4.46%10
SLNSilence Therapeutics plc
$19.80+0.10%10
VCNXVaccinex, Inc.
$0.70-1.39%10
ELABPMGC Holdings Inc.
$1.92-1.03%20
BTAIBioXcel Therapeutics, Inc.
$0.01-3.60%30
QUCYQuantum Cyber N.V.
$0.74+2.62%10
MREOMereo BioPharma Group plc
$0.30+4.12%10

Spot a number that looks wrong? Check it in ONCO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ONCO

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.